Molecular chaperones: cancer dependence and druggability
19 Jan 2011
Molecular chaperones: cancer dependence and druggability
Chemoradiotherapy for bladder cancer
Raising public awareness of HPV induced malignancy
Advances in the treatment of renal cancer
The role of radiotherapy in the treatment of prostate cancer
Patients as partners in oncopolicy
World Health Organisation cancer prevention and control
The European Academy of Cancer Sciences
Prostate screening and the Forum Against Cancer Europe
How to select targeted therapy in renal cancer
The development of PARP inhibitors a new drug to treat prostate cancer
Cyberknife robotic radiosurgery